Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
US9278100B2 · kind B2 · utility
37Cited by
32References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2011 |
| Grant date | Mar 8, 2016 |
| Priority date | — |
| Expiry date | May 1, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/243
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.